Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Q
Qato, Danya
University of Maryland, Baltimore
Longitudinal Treatment Pathways Following Opioid Use Disorder Diagnosis Among Commercially-Insured Beneficiaries in the U.S.
Location:Room IV
Danya Qato
Impact of the US Food and Drug Administration Warning for Increased Risk of Aortic Aneurysms or Dissections on Fluoroquinolone Prescribing Trends
Location:Room XV
Danya Qato
Quesinberry, Dana
University of Kentucky, College of Public Health
Methodology for Identifying Single-drug Involved Poisoning Deaths: Application to Gabapentin-involved Drug Poisoning Death Surveillance
Location:Room III
Dana Quesinberry
Quint, Jennifer
National Heart & Lung Institute, Imperial College London
Using probabilistic bias analysis to account for outcome misclassification of COVID-19 death in pharmacoepidemiologic studies
Location:Conv Hall I C
Jennifer Quint
Qvist, Tavs
Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
Real-world outcomes: Lung clearance index improvements in Danish children with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.
Location:Room XV
Tavs Qvist
